Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

Albert FontBegona MelladoMiguel A ClimentJuan Antonio VirizuelaStephane OudardJavier PuenteDaniel CastellanoAranzazu González-Del-AlbaAlvaro PintoRafael Morales-BarreraAlejo Rodriguez-VidaPedro L FernandezCristina TeixidoPedro JaresIban AldecoaNeil GibsonFlavio SolcaShoubhik MondalRobert M LorenceJosep SerraFrancisco X Real

Published in: British journal of cancer (2023)

NCT02780687.

Keyphrases

tyrosine kinase
spinal cord injury
epidermal growth factor receptor
genome wide
open label
advanced non small cell lung cancer
copy number
urinary tract
randomized controlled trial
clinical trial
dna methylation
double blind